BBNX Stock Analysis: Buy, Sell, or Hold?
BBNX - Beta Bionics, Inc. Common Stock
$13.83
-0.96 (-6.49%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 17, 2026
16d
Get Alerted When BBNX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BBNX is down 13.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BBNX is down 13.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BBNX is currently trading at $13.83, which is considered oversold relative to its 30-day fair value range of $17.34 to $31.37.
Technical Outlook: Technically, BBNX is showing sideways momentum. The price is currently testing key support at $13.77. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.45 (+105.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BBNX is showing sideways momentum. The price is currently testing key support at $13.77. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.5% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $30.45 (+105.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$17.34 -
$31.37
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding BBNX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.5%)
- BULLISH: Trading 105.9% below Wall St target ($30.45)
- WARNING: Recommendation downgraded due to -13.3% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$17.34 -
$31.37
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$13.77
Resistance Level
$19.03
Current Trend
Sideways
Fundamental Context
Forward P/E (Next Year Est.)
-8.67
Wall Street Target
$30.45
(+105.9%)
Revenue Growth (YoY)
63.1%
Profit Margin
-87.9%
Last updated: January 31, 2026 1:05 AM ET
Data refreshes hourly during market hours. Next update: 2:05 AM
Data refreshes hourly during market hours. Next update: 2:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BBNX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
12
Sells
Net
INSIDERS SELLING
Recent Transactions
Stephen Feider
SELL
4982 shares
2025-10-03
Stephen Feider
SELL
15018 shares
2025-10-01
Mark Hopman
SELL
11411 shares
2025-09-05
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$374 | 54 HOLD |
Advanced BBNX Option Strategies
Professional options setups generated by AI based on today's BBNX price and gamma walls.
